We are looking forward to our poster presentation at the 60th Anniversary Meeting of The British Association for Cancer Research starting in Nottingham on Sunday.
Learn more: https://t.co/OpWvZOZsff
#BACR#Scandion#SCOL#oncology#cancer
Edison Investment Research has today published its initial analysis of Scandion Oncology.
With its global audience Edison will support the profiling of Scandion towards the international investment community.
You can find the analysis here: https://t.co/bZRy5j5ymB
#Scandion
We are excited to announce the appointment of Dr. Alfredo Zurlo as Chief Medical Officer (CMO) at Scandion Oncology. Alfredo joins immediately as part of the company’s Executive Management.
Read more: https://t.co/ir4cC9Tlej
#Scandion#SCOL#oncology#cancer
We extend our thanks to the audience participating at President and CEO Bo Rode Hansen’s presentation at the Anglonordic Life Science Conference in London yesterday.
#Scandion#SCOL#oncology#cancer
Scandion Oncology turns five today and is quite a big five-year-old! We have grown to a team of 15 dedicated colleagues who go to work everyday to help develop medicines that can revert cancer’s resistance to treatment and make existing cancer treatments work better and longer.
Our Annual General Meeting (AGM) will be held on Wednesday, April 27 at 4 PM CET in Copenhagen, Denmark.
3 new members of the Board of Directors are nominated for election at the AGM. Learn more at https://t.co/EdhTszIzj7
#Scandion#SCOL
WOW vilka rekryteringar till BoD;
Keld Flintholm Jørgensen - EVP & CBO från Lundbeck
Martine van Vugt - SVP Corporate strategy and Planning från Genmab
Alejandra Mørk - CEO KLIFO A/S
🤩
Det blir mer och mer spännande med utläsning av studierna nu i Q2/Q3
We are looking forward to participating in the ACCESS CHINA Biotech Forum 2022 conference next week with a presentation by Mads Aaboe Jensen, VP of Business Development and Innovation.
https://t.co/4CuOPRnpiX
#Scandion#SCOL#oncology#cancer